BioSpace News Archive

The TIME 100 Health Summit and the TIME 100 Next Summit Will Convene in New York, NY This Fall

River Ridge Dermatology welcomed two new resident physicians, Karla Guerra, D.O. and Abby Russell, D.O., and bid farewell to Dr. Nathan Miller, who completed his residency.

Henry Ford Health System and Health Alliance Plan (HAP), a nonprofit health plan and operating unit of Henry Ford, announced today that HAP’s acquisition of Trusted HP – Michigan has received all regulatory approvals and the acquisition became effective on September 13, 2019.

SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Gaëtan Fraikin and Sergei Yakneen have joined its executive team as Chief Marketing Officer and Chief Information Officer, respectively

The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, presents its most recent “Peer Exchange” panel discussion, “The Challenges and Treatment of Sickle Cell Disease.”

The AKC Canine Health Foundation announces the receipt of a $5.9 million bequest from a private, anonymous donor.

icotec Medical, Inc. a US-based subsidiary of Swiss icotec AG today announced that it will unveil its VADER®one pedicle screw system during the 34th annual meeting of the North American Spine Society in Chicago, September 25-28, 2019.

Hillrom (NYSE: HRC), will host its fiscal fourth quarter 2019 earnings conference call and webcast on Friday, November 1, 2019, beginning at 7:00 a.m. (CT) / 8:00 a.m. (ET)

Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers, today announced that a poster will be presented at the European Society for Medical Oncology (ESMO), being held in Barcelona, Spain from September 27 to October 1, 2019.

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, will present new data from a Phase 2 clinical trial evaluating tavapadon (formerly PF-06649751) in patients with early-stage Parkinson’s disease at the 2019 International Congress of Parkinson’s Disease and Movement Disorders®, taking place from September 22-26 in Nice, France.